Stock Market Crash: Cannabis Stocks May Finally Be Worth Looking At!

After underperforming, cannabis stocks like Aphria Inc (TSX:APHA)(NYSE:APHA) may finally be worth looking at.

| More on:
Cannabis stocks have fallen.

In 2020, the COVID-19 pandemic is wreaking havoc on a number of industries. Legal cannabis, it seems, isn’t one of them. According to data from the cannabis analytics company Headset, legal marijuana sales spiked in five U.S. states last week, as residents prepared to shelter at home. Marijuana Business Daily reported a similar spike in Canada, with one store owner reporting a 20% increase in sales.

The data we’re seeing on marijuana sales is consistent with long- established economic trends. In past recessions, it has been observed that sales of alcohol and tobacco spike as consumers seek respite from difficult times. Legal cannabis would fall into the same category. As a “vice” product, it’s the exactly the type of item you’d expect consumers to buy when times are tough.

Which brings us to cannabis stocks. Over the past year, they’ve been among the worst-performing stocks on the TSX, falling precipitously since the day cannabis was legalized. Mounting losses have been the main culprit for the problem, with regulatory headaches a distant second. Now, however, cannabis stocks are cheaper than ever, and poised to see revenue soar. The question is, does that make them buys?

Marijuana stocks have gotten cheaper

One reason for considering cannabis stocks right now is that they’ve gotten cheaper. Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is currently trading at 1.23 times book value, while Aphria Inc (TSX:APHA)(NYSE:APHA) trades at 2.26 times sales and 0.6 times book value.

This is the cheapest we’ve seen these stocks in a long time. Immediately before legalization, Canopy was trading at well over 30 times sales, with other cannabis stocks having similar valuations. So these stocks are getting cheaper at the same time as marijuana sales are increasing. That certainly seems like a reason to buy. However, we still need to look at the question of profitability.

Some cannabis companies showing signs of profit potential

For the longest time, profitability was the big question mark hanging over the cannabis industry. While it’s normal for young companies to run losses, the staggering losses seen in ‘big weed’ have really been something else. Canopy Growth posted a $1.3 billion loss for a single quarter recently, while Aurora Cannabis took a billion dollar impairment charge.

It’s not surprising that these colossal losses would lead to depressed stock prices. However, more recently, we’ve been seeing encouraging signs on the profitability front. Recently, Aphria posted two consecutive profitable quarters. Its most recent quarter was a loser, but the loss was small as a percentage of sales. Canopy on the other hand had a $124 million loss in the third quarter. That’s a pretty big loss, but it’s down from a $374 million loss in the prior quarter.

Overall, I’m still not optimistic that cannabis companies will broadly move toward profitability. However, we’re starting to see some individual companies like Aphria set themselves apart from the pack. These stocks may finally be worth considering in light of their cheaper prices.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Coronavirus

A stock price graph showing declines
Dividend Stocks

Here’s Why I’m Confident About Investing Through the Down Market

There is no bear market in history that has not been followed by a bull cycle. Rather than fret over…

Read more »

Doctor talking to a patient in the corridor of a hospital.
Coronavirus

3 Top TSX Healthcare Stocks to Buy in October

Healthcare stocks soared during the pandemic, and are now down in the dumps. But these three could make a huge…

Read more »

movies, theatre, popcorn
Coronavirus

How Much is $1000 in AMC Stock Worth 1 Year Later?

AMC was once a stellar growth stock, but it’s taken a serious hit. So how much is $1,000 worth a…

Read more »

Airport and plane
Coronavirus

Air Canada Stock Could Keep Trading Weak as Challenges Mount

Should you buy AC stock?

Read more »

Arrow descending on a graph
Coronavirus

Why Cineplex (TSX:CGX) Stock Fell to 2-Year Lows Last Week

Is the recent correction in CGX stock really an opportunity?

Read more »

Business success with growing, rising charts and businessman in background
Coronavirus

1 Growth Stock Every Canadian Investor Should Consider Right Now

This growth stock saw shares pop 10% on June 20, as one analyst stated there is a significant opportunity to…

Read more »

Aircraft wing plane
Coronavirus

Bombardier Stock Merge: What it Means for Investors

Bombardier (TSX:BBD.B) stock went through a reverse stock split on June 13, turning 25 shares into one in one swift…

Read more »

Aircraft wing plane
Coronavirus

Air Canada (TSX:AC) Stock: Ready to Take Off?

While Air Canada is handling what it can control really well, there are many worsening macro headwinds that will likely…

Read more »